| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.28 | 1e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |